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Differentiation between simple cyst and hepatic
hemangioma utilizing T2-weighted magnetic resonance
imaging with gradient-echo (b-FFE) technique*
Diferenciação entre cisto simples e hemangioma hepático utilizando seqüência
de ressonância magnética ponderada em T2 com técnica gradiente-eco (B-FFE)
Carolina Valente Burim1, Luiz Pecci Neto2, Fabiola Goda Torlai2, Dario Ariel Tiferes3,
Giuseppe D’Ippolito4
OBJECTIVE: To establish the role of MRI T2-weighted sequences in the differentiation between simple cysts
and hepatic hemangiomas. MATERIALS AND METHODS: A double-blinded, prospective, observational, cross-
sectional study evaluated 52 patients with 91 hepatic lesions (34 simple cysts and 57 hemangiomas) submitted
to abdominal magnetic resonance imaging. The combined analysis of all sequences was considered as the
golden-standard. TSE sequences with long echo trains and b-FFE sequences were subjectively analyzed by
two independent observers for differentiating cysts from hemangiomas. The kappa test (κ) was utilized in
the analysis of the methods accuracy and inter- and intra-observer agreement (p < 0.05*). RESULTS: Cysts
and hemangiomas dimensions ranged respectively between 0.5 and 6.5 cm (mean = 1.89 cm), and 0.8 and
11 cm (mean = 2.62 cm). The analysis of the sequences with long-TE and the golden-standard demonstrated
a non-statistically significant agreement (κ: 0.00–0.10). The agreement between the evaluation of the b-FFE
sequence and the golden-standard ranged from substantial (κ: 0.62–0.71) to almost perfect (κ: 0.86) for
both observers. The inter- and intra-observer agreement for the b-FFE sequence ranged from substantial (κ:
0.62–0.70) to almost perfect (κ: 0.85–0.91). CONCLUSION: T2-weighted images acquired with the b-FFE
technique present a high accuracy and reproducibility in the differentiation between cysts and hepatic
hemangiomas.
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OBJETIVO: Estabelecer o valor das seqüências ponderadas em T2 para diferenciar cistos simples de heman-
giomas hepáticos. MATERIAIS E MÉTODOS: Estudo prospectivo, observacional, transversal e duplo-cego
em 52 pacientes com 91 lesões hepáticas (34 cistos simples e 57 hemangiomas) submetidos a ressonância
magnética de abdome. A análise conjunta de todas as seqüências realizadas foi considerada o padrão-ouro.
Dois observadores independentes avaliaram, subjetivamente, as seqüências TSE com TE longo e B-FFE,
procurando diferenciar cistos de hemangiomas. Foram calculadas a eficácia das seqüências e a concordân-
cia interobservador e intra-observador por meio do teste kappa (κ) (p < 0,05*). RESULTADOS: As dimen-
sões dos cistos variaram entre 0,5 e 6,5 cm (média de 1,89 cm) e as dos hemangiomas, entre 0,8 e 11 cm
(média de 2,62 cm). A concordância entre a avaliação da seqüência com TE longo e o padrão-ouro foi insig-
nificante (κ: 0,00–0,10). A concordância entre a avaliação da seqüência B-FFE e o padrão-ouro variou de
substancial (κ: 0,62–0,71) a quase perfeita (κ: 0,86) para ambos os examinadores. A concordância interob-
servador e intra-observador para a seqüência B-FFE variou entre substancial (κ: 0,62–0,70) e quase perfeita
(κ: 0,85–0,91). CONCLUSÃO: A técnica B-FFE apresenta eficácia e reprodutibilidade elevadas na diferencia-
ção de cistos e hemangiomas.
Unitermos: Fígado; Cisto; Hemangioma; Imagem por ressonância magnética.
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INTRODUCTION
Magnetic resonance imaging (MRI) has
been frequently utilized for detecting and
characterizing hepatic nodules, among
other applications in the evaluation of ab-
dominal diseases(1). Hepatic nodules are
frequently found on abdominal MRI stud-
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ies and must be characterized. In some
cases MRI results can be correlated with
those previously found at ultrasonography
(US) and computed tomography (CT), al-
lowing a complementary diagnosis. In
other cases, these methods are not available
or simply have not been performed, so MRI
becomes the single source of information
for guiding the hepatic nodule characteriza-
tion. Amongst the hepatic nodules, heman-
giomas and simple cysts are the most fre-
quently found and can be present in up to
20% in cases of autopsy(2).
At non-contrast-enhanced MRI, hepatic
hemangiomas and simple cysts present
similar behavior in signals, characterized
by nodular, hypointense images on T1-
weighted sequences and hyperintense on
T2-weighted sequences, with no signifi-
cant signal loss when long echo times (TE
> 140 ms) are used(3), differently from other
types of hepatic nodules such as hepatocar-
cinomas or metastases where signal loss
can be observed as TE is extended on T2-
weighted images(3). Because of the similar-
ity between the signals of these lesions,
intravenous paramagnetic contrast (gado-
linium) injection is required for differen-
tiation between cysts and hemangiomas(1,4).
Despite the safety and low toxicity of
the gadolinium-based paramagnetic con-
trast agents, especially as compared with
iodinated contrast agents, the utilization of
this type of contrast agent increases the cost
of the study. Additionally, most recently, an
association between the utilization of ga-
dolinium and the development of systemic
nephrogenic fibrosis has been reported in
patients with chronic renal failure, thus
limiting in some way the utilization of
gadolinium-based contrast agents(5).
Some authors have successfully de-
voted themselves to the study of the differ-
entiation between hepatic cysts and heman-
giomas based only on T2-weighted se-
quences, without the utilization of para-
magnetic contrast injections(4,6). Recently
a pulse gradient-echo sequence was devel-
oped with a balanced gradient structure
(balanced-FFE – b-FFE), allowing the ac-
quisition of T2-weighted sequences in
short acquisition times and without the
presence of motion artifacts resulting from
respiration(7). The authors have observed
that this sequence would allow the differ-
entiation between hepatic hemangiomas
and simple cysts without the necessity of
intravenous contrast-enhancement, be-
cause of the hemangiomas signal loss, dif-
ferently from the behavior presented by
simple cysts.
The present study was aimed at evalu-
ating the role of MRI T2-weighted images
in the differentiation between hepatic
simple cysts and hemangiomas.
MATERIALS AND METHODS
In the period between February 2005
and February 2006, the authors developed
a prospective, observational, cross-sec-
tional, double-blinded study analyzing gra-
dient-echo b-FFE abdominal MRI images
of 52 patients with a total of 91 lesions
corresponding to 34 simple cysts and 57
hepatic hemangiomas diagnosed by con-
trast-enhanced MRI. The group of patients
included 36 women and 16 men with ages
ranging from 23 to 80 years (mean = 47.5
years). The research protocol of the present
study was approved by the Committee for
Ethics in Research (Project No. 0922/05)
of Universidade Federal de São Paulo/Hos-
pital São Paulo, and by the Committee for
Ethics in Research (Project No. 092/2005)
of Beneficência Médica Brasileira S/A –
Hospital e Maternidade São Luiz.
The studies were performed in a 1.0 T
MRI equipment Gyroscan NT10 (Philips
Medical Systems; Best, The Netherlands)
(45 patients with 30 cysts and 48 heman-
giomas) and a 1.5 T Intera ACS NT15 (Phi-
lips Medical Systems; Best, The Nether-
lands) (7 patients with 4 cysts and 9 heman-
giomas), respectively with body and syn-
ergy coils. The paramagnetic contrast agent
was administered through a Medrad injec-
tion pump to patients after four-hour fast-
ing. All of them were intravenously admin-
istered butylscopolammonium bromide (1
ml diluted in 10 ml sodium solution) im-
mediately before the examination through
a Gelco 18-20 gauge catheter into an an-
tecubital calibrous vein to allow a safe and
adequate contrast injection. All of the pa-
tients received a dose of 0.2ml/kg of para-
magnetic contrast agent (Gd-DTPA), at an
injection rate of 2 ml/s. Contrast-enhanced
images were acquired 20 seconds (arterial
phase), 60 seconds (portal phase) and five
minutes (equilibrium phase) after the intra-
venous contrast injection was initiated.
The sequences utilized with the 1.0 T
and 1.5 T equipments as well as the respec-
tive technical parameters are summarized
on Tables 1 and 2.
The golden-standard for determining
the nature of the nodule (simple cyst or
hemangioma) was defined by a radiologist
with an extensive experience in abdominal
MRI who analyzed all the T1- and T2-
weighted with short and long TE, the im-
ages of the b-FFE sequences, and those
acquired after paramagnetic contrast injec-
tion. Simple cysts were those lesions with
the following MRI findings: well-defined
hypointense nodule at T1-weighted, and
hyperintense at T2-weighted images, with
no apparent signal loss with the longer echo
times (TE = 140 ms), homogeneous con-
tents, absence of septa or vegetations, and
with no contrast-enhancement after para-
magnetic contrast injection(8) (Figure 1).
Hemangiomas were those lesions with the
following MRI findings: well-defined
hypointense nodule at T1- and hyperin-
tense at T2-weighted sequences, even with
the longest echo times (TE = 140 ms) and
peripheral globular enhancement with cen-
tripetal fill-in or early and progressive ho-
mogeneous enhancement, without distor-
tion of adjacent vessels or hepatic capsule
retraction(8) (Figure 2).
Images analysis
The images were interpreted by two in-
dependent observers with one-year educa-
tion in abdominal MRI, who had no previ-
ous knowledge of the US, CT and contrast-
enhanced MRI results. The analysis of the
images was performed on an EasyVision
workstation (Philips Medical Systems;
Best, The Netherlands) or on the MRI
equipment console, specifically focusing
on the localization and diameter of previ-
ously identified nodules.
Only the T2-weighted sequences were
evaluated by the two observers who subjec-
tively classified the hepatic lesions into
either simple cysts or hemangiomas ac-
cording to the findings at T2-weighted
images, adopting the sequences obtained
with short TE (TE = 70–90 ms), long TE
(TE = 140 ms) and b-FFE as parameters.
Simple cysts were those lesions that did not
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Table 1 Technical parameters for sequences utilized with the 1.0 T equipment.
Parameters
FOV
RFOV
Matrix
Reconstruction matrix
Thickness
Gap
Flip angle
TR
TE
Number of sections
Respiratory synchronization
Technique
Axial T2 SPIR
400 mm
80%
352
512
8 mm
0.8
100°
1,800 ms
90
23
Yes
SE
Axial T2 TSE
400 mm
90%
352
512
8 mm
0.8
90°
1,800 ms
140
23
Yes
SE
Axial T1 in
400 mm
100%
304
512
8 mm
0.8
15°
14.1 ms
6.91
23
No
FFE
Axial T1 out
400 mm
100%
304
512
8 mm
0.8
15°
14 ms
3.45
23
No
FFE
b-FFE
400 mm
100%
192
256
8 mm
0.8
90°
6.4 ms
3.1
23
Yes
FFE
Axial T1 dynamic
400 mm
60%
240
256
8 mm
0.8
80°
163.7 ms
2.3
23
No
FFE
Table 2 Technical parameters for sequences utilized with the 1.5 T equipment.
Parameters
FOV
RFOV
Matrix
Reconstruction matrix
Thickness
Gap
Flip angle
TR
TE
Number of sections
Respiratory synchronization
Technique
Axial T2 SPIR
450
80%
256
512
7 mm
1 mm
90°
1,800 ms
70
23
Yes
SE
Axial T2 TSE
450
70%
256
512
7 mm
1 mm
90°
1,800 ms
140
23
Yes
SE
Axial T1 in/out
400
70%
192
256
7 mm
1 mm
80°
158 ms
2.3/4.6
23
No
FFE
Axial B-FFE
450
100%
192
256
14 mm
–7 mm
80°
3.2 ms
1.61
24
Yes
FFE
Axial T1 dynamic
420
90%
256
512
7 mm
1 mm
70°
2.45 ms
5.4
23
No
FFE
Figure 1. Simple hepatic cyst (arrow): hypointense on T1-weighted (A), hyperintense on T2-weighted image (B), and no enhancement is seen after intrave-
nous contrast injection (C).
present signal loss on the long TE or b-FFE
sequences as compared with the short TE
sequences (Figure 3), and hemangiomas
were those with apparent signal loss on
these sequences (Figure 4).
The images were independent and
blindly analyzed by the two observers at
three different moments with a minimum
15-day interval, as follows: moment 1 (M1)
— comparison between results with short-
TE and long TE for determining the value
of long TE sequences; moment 2 (M2) —
first comparison between short TE and b-
FFE sequences for determining the value of
the b-FFE sequence and allowing the cal-
culation of the interobserver agreement;
moment 3 (M3) — second comparison be-
tween short TE and b-FFE sequences to
allow the calculation of the interobserver
agreement.
Statistical analysis
Intra- and interobserver agreements were
calculated by means of the kappa index (κ)
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Figure 2. Hepatic hemangioma (arrow): hypointense on T1-weighted (A), hyperintense on T2-weighted
image (B), early globular enhancement (C) and late homogeneous enhancement (D) after intravenous
contrast injection.
Figure 3. Simple hepatic cyst (arrow) with no signal loss on T2-weighted long TE sequence (A) and b-FFE (B) as compared with T2-weighted short TE sequence (C).
Figure 4. Hepatic hemangioma (arrow) with signal loss on T2-weighted long TE sequences (A) and more noticeable on b-FFE sequence (B) as compared with
T2-weighted short TE image (C).
and the significance level (p) adopted was
0.05 (α = 5%)(15).
RESULTS
Hepatic nodules localization and dimen-
sions
The cysts evaluated in the present study
ranged from 0.5 to 6.5 cm in diameter
(mean 1.89 cm). The distribution of the
cysts and over hepatic segments is demon-
strated on Table 3.
The hemangiomas diameter ranged be-
tween 0.8 and 11 cm (mean 2.62 cm). The
distribution of the hemangiomas over he-
patic segments is demonstrated on Table 3.
Value of T2-weighted sequences
The agreement between the analysis of
TSE sequence with long TE (M1) and the
golden-standard was poor and non-signifi-
cant for both observers (κ: 0.10 and κ: 0.00;
p = 0.196 and p= 0.883; non-significant).
The agreement between the b-FFE (M2
and M3) sequence and the golden-standard
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Table 3 Distribution of cysts and hemangiomas
over hepatic segments.
Hepatic
segment
I
II
III
IV
V
VI
VII
VIII
II/III
IV/VIII
V/VI
V/VII
V/VII/VIII
VI/VII
VII/VIII
Number
of cysts
1
2
3
9
3
1
4
8
2
1
0
0
0
0
0
Number
of hemangiomas
2
5
0
7
6
3
9
13
4
1
1
1
1
1
3
ranged from substantial (κ: 0.62 and 0.71)
to almost perfect (κ: 0.86) and was statis-
tically significant (p < 0.001*).
The interobserver agreement was con-
sidered as substantial in both moments of
the analysis (κ: 0.62–0.70). The intra-ob-
server agreement in relation to the evalua-
tions at moments M2 and M3 was consid-
ered as almost perfect (κ: 0.85–0.91) for
both observers.
Statistical differences between the
groups of patients evaluated with the 1.0 T
and 1.5 T systems could not be calculated
because of the small number (n = 7) of stud-
ies performed with the 1.5 T MRI system.
DISCUSSION
MRI has been frequently utilized for
detecting and characterizing hepatic nod-
ules among other applications in the evalu-
ation of abdominal diseases(1). In this con-
text, hepatic nodules are most frequently
found, the benign ones corresponding to
simple cysts present in 2%–7% of the gen-
eral population, and hemangiomas present
in up to 20% of cases of autopsy(2,8). Gen-
erally these nodules are asymptomatic,
being incidentally found on imaging stud-
ies. Diagnosis confirmation in these cases
is most frequently achieved by means of a
combination of imaging methods including
US, CT and/or MRI(4,8). Hepatic simple
cysts and hemangiomas are considered as
benign lesions, representing a diagnostic
challenge considering that, at imaging stud-
ies, these lesion could be mistaken with
primary of secondary malignant neo-
plasms, leading to unnecessary surgical
procedures or incorrect cancer staging(8).
MRI is considered as a reliable method for
detecting and characterizing hepatic le-
sions. Advantages of this method include
multiplanar imaging capability, higher
specificity due to T2-weighted images, and
absence of ionizing radiation and more
nephrotoxic iodine-based contrast agents
like those utilized at CT(8). The strategy
adopted in MRI studies for differentiation
between benign and malignant hepatic
nodules combines a visual evaluation of
signal intensity on dynamic contrast-en-
hanced, heavily T2-weighted and T1-
weighted images. Among benign nodules,
cysts and hemangiomas are most frequently
found, both presenting high signal intensity
on T2-weighted sequences with longer
echo times (ex.: TE = 140 ms), differently
from metastases and hepatocarcinoma,
which present with lower signal intensity
on this type of sequence(1,3). On the other
hand, the paramagnetic contrast injection
allows the completion of this differentia-
tion through the analysis of the hepatic
nodule enhancement pattern(9). So, consid-
ering the similarity of signal intensity be-
tween cysts and hemangiomas, paramag-
netic contrast (Gd-DTPA) injection be-
comes necessary for differentiation be-
tween these lesions. Cysts do not enhance
after administration of Gd-DTPA, and he-
mangiomas present an early, discontinuous
peripheral, progressive and centripetal en-
hancement(2,8). Despite of the safety and
low toxicity, especially as compared with
iodinated contrast agents, the utilization of
a paramagnetic contrast agent results in an
increase in the cost of the study. Addition-
ally, recent studies have demonstrated an
association between the utilization of ga-
dolinium and the development of nephro-
genic systemic fibrosis in patients with
chronic renal failure(5).
Some limitations related to the utiliza-
tion of gadolinium-based contrast agents,
and the possibility of MRI becoming a
completely non-invasive method for differ-
entiating hepatic cysts from hemangiomas
have lead some authors to perform such
differentiation without utilizing intrave-
nous contrast injection, with quite signifi-
cant rates of success(4,6). However, it is
important to observe that these authors
have not evaluated the accuracy of the
method through the calculation of intra-
observer agreement, raising the necessity of
a further prospective evaluation of a higher
number of lesions like the present study.
Additionally, the sequences performed re-
quired several acquisitions and breath-
holds for evaluating the whole liver, which
could extend the acquisition time, besides
failing in the detection of all the hepatic
lesions present(6).
A sequence available in the majority of
modern MRI systems (b-FFE) was utilized
in the present study, with short acquisition
time (< 60 seconds), low sensitivity to ar-
tifacts and not requiring breath-hold or res-
piratory synchronization, a method feasible
for patients with limited ventilator capac-
ity(10).
The present prospective study was de-
signed to allow a comparison of the b-FFE
sequence with the golden-standard in the
characterization of hemangiomas, i.e., TSE
with long TE(4,11,12). So, the authors sought
to establish the role of this sequence in the
differentiation between hemangiomas and
cysts, which had not been proposed in the
literature yet. For this purpose, MRI was
established as a golden-standard encom-
passing all the sequences adopted in the
routine investigation of hepatic nodules,
including contrast-enhanced sequences
during arterial, portal venous and equilib-
rium phases(9). This golden-standard has
been utilized by the authors of the present
study and by others, and also has been ac-
cepted in the literature as a reliable method
for evaluating the effectiveness of new
MRI sequences for detecting or character-
izing hepatic nodules(6,12).
The results of the present study demon-
strated that the b-FFE sequence is not only
more effective than TSE with long TE, but
also is more accurate, with a considerably
high inter-observer agreement. It is impor-
tant to observe that, in the present sample,
the authors evaluated nodules with up to
0.5 cm in diameter, localized in different
segments of the liver, with no difficulty in
differentiating cysts from hemangiomas,
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even in the case of nodules < 1.0 cm. In
cases of small hepatic nodules (< 1.0 cm)
MRI sequences traditionally utilized may
present a low accuracy(13).
In the present study, both the observers
had only one year of experience after the
period of residency in imaging diagnosis,
which corroborates the simplicity of the
method and the short learning curve. It took
only one training session to instruct the two
observers about the criteria adopted in the
images analysis.
Some criticisms could be raised against
the present study. Firstly, only hemangio-
mas considered as typical, corresponding
to about 80% of all hepatic hemangiomas,
were evaluated(14). Results including atypi-
cal hemangiomas such as sclerosing he-
mangiomas or hemangiomas with intra-
lesional hemorrhage, are still to be known.
On the other hand, considering the utiliza-
tion of MRI as a golden-standard, atypical
hemangiomas could not be included be-
cause its etiology could not be confirmed
unless a long-term follow-up was under-
taken or a biopsy was performed for
anatomopathological analysis. It is impor-
tant to note that hemangiomas can develop
with time and evolutive controls not always
are reliable to prove the etiology of the le-
sion(14).
Among the patients of the present
sample, those with a history of malignant
neoplasm were excluded, considering that
some tumor result in cystic hepatic metasta-
sis that may manifest as atypical cysts, with
intracystic hemorrhage or a thick content of
other nature(15). Therefore, only patients
with simple hepatic cysts were evaluated.
Probably, the results would be different if
patients with complex hepatic cysts had
been included, considering that the behav-
ior of these lesions on T2-weighted images
is quite different from the simple cysts(15).
Also, the authors could not determine the
results for patients with hepatic steatosis,
since these patients were not included in
the present sample. This variable should
still be evaluated, considering that hepatic
steatosis may affect the hepatic paren-
chyma signal intensity on T2-weighted
images with fat-suppression (SPIR), like
those utilized in the present study(16).
The evaluation of an objective param-
eter, for example, the nodule/liver signal
ratio could add subsidiary results for the
differentiation between cysts and heman-
giomas on the different sequences utilized
and this is a reason for continuing the
present study whose results should be re-
ported in a near future.
Finally, the results of the present study
indicate that the bFFE sequence plays a
significant role in the routine MRI evalua-
tion of the liver, considering that this is a
fast sequence, with a relatively low sensi-
tivity to motion or respiratory artifacts and
high effectiveness and accuracy in the dif-
ferentiation between simple cysts and he-
patic hemangiomas. Despite not requiring
the utilization of paramagnetic contrast
agent for this differentiation, gadolinium-
based contrast agent is still necessary in
liver MRI for detection and characteriza-
tion of a wide range of focal hepatic le-
sions(9,17,18).
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